NGL Fine-Chem Ltd.
NSE :
NGLFINEBSE :
524774ISIN CODE :
INE887E01022Industry :
Pharmaceuticals & DrugsHouse :
Private
BSE2,381.7044.70 (1.91 %)
PREV CLOSE() 2,337.00
OPEN PRICE () 2,398.00
BID PRICE (QTY) 2,377.00(4.00)
OFFER PRICE (QTY) 2,410.00(3.00)
VOLUME 926
TODAY'S LOW / HIGH()
52 WK LOW / HIGH ()
STOCK SUMMARY
Incorporation Year :
1981
Management Info :
Dhananjay Mungale - Chairman Rahul Nachane - Managing DirectorRegistered Office :
Address :
301 E Square,Subhash Road,Vile Parle (East),
Mumbai,
Maharashtra-400057
Phone : 022 26636450
Email : info@nglfinechem.com
Website : www.nglfinechem.com
Registrar's Details :
Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
Listing :
BSE, NSE
13Mar NGL Fine-Chem informs abo..Pursuant to Regulation 30 read with Schedule III of the SEBI Listing Obl..
03Jan NGL Fine-Chem informs ab..Based on the confirmation received from Purva Sharegistry (I), Registrar..
25Jul NGL Fine-Chem submits BRSR
Pursuant to Regulation 34(2)(f) of the Securities and Exchange Board of ..
Pursuant to Regulation 34(2)(f) of the Securities and Exchange Board of ..
10Jul NGL Fine Chem informs abo..NGL Fine Chem has informed that it enclosed compliance certificate under..
27Jun NGL Fine-Chem informs abo..Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
Neuland Laboratories (BSE) 14,519.70 (3.34%) | M.Cap ( in Cr) 18618.73 |
| Astrazeneca Pharma I (BSE) 8,026.25 (1.71%) | M.Cap ( in Cr) 20147.75 |
| Alkem Laboratories (BSE) 5,376.50 (2.47%) | M.Cap ( in Cr) 64325.97 |
| Sanofi Cons. Health (BSE) 4,596.25 (2.74%) | M.Cap ( in Cr) 10601.23 |
| Albert David (BSE) 752.95 (12.51%) | M.Cap ( in Cr) 413.2 |
| Scheme Name | Hold(%) |
|---|---|
| Bandhan BSE Healthca... | 0.01 |
| Motilal Oswal BSE He... | 0.01 |
